Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Ex-Vivo Expansion and mRNA Transfection of Cord Blood Derived Natural Killer Cells with Preserved Cytotoxicity.

Hande H. Tuncer, MD, Monica M. Betancur, MSc., Laurent H. Boissel, PhD, Robb S. Friedman, MD, Hans G. Klingemann, MD,PhD

Blood (2006) 108 (11): 3659.

https://doi.org/10.1182/blood.V108.11.3659.3659

Published: 2006

Journal Articles

Single Antigen Mismatched Related Donor Allogeneic Stem Transplants Have Similar Outcomes as Matched Unrelated Donor Allogeneic Stem Cell Transplants: A Single Center’s Experience.

Benjamin Newton, MD, Kellie A. Sprague, MD, Andreas K. Klein, MD, Hans G. Klingemann, MD, PhD, Geoffrey W. Chan, MD

Blood (2005) 106 (11): 2061.

https://doi.org/10.1182/blood.V106.11.2061.2061

Published: 2005

Journal Articles

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

Damiano Rondelli, Giovanni Barosi, Andrea Bacigalupo, Josef T. Prchal, Uday Popat, Emilio P. Alessandrino, Jerry L. Spivak, B. Douglas Smith, Hans G. Klingemann, Steven Fruchtman, Ronald Hoffman

Blood (2005) 105 (10): 4115–4119.

https://doi.org/10.1182/blood-2004-11-4299

Published: 2005

Journal Articles

Induction of Multiple Myeloma-Specific Cytotoxic T Lymphocytes Using HLA-A2.1-Specific CD19 and CD20 Peptides.

Jooeun Bae, Ph.D., Jeff A. Martinson, B.S., Hans G. Klingemann, M.D., Steven Treon, M.D., Kenneth C. Anderson, M.D., Nikhil C. Munshi, M.D.

Blood (2004) 104 (11): 2477.

https://doi.org/10.1182/blood.V104.11.2477.2477

Published: 2004

Journal Articles

Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation

Thomas J. Nevill, Henry C. Fung, John D. Shepherd, Douglas E. Horsman, Stephen H. Nantel, Hans-G. Klingemann, Donna L. Forrest, Cynthia L. Toze, Heather J. Sutherland, Donna E. Hogge, Sheldon C. Naiman, Alan Le, Daphne A. Brockington, Michael J. Barnett

Blood (1998) 92 (6): 1910–1917.

https://doi.org/10.1182/blood.V92.6.1910

Published: 1998

NARROW

Ex-Vivo Expansion and mRNA Transfection of Cord Blood Derived Natural Killer Cells with Preserved Cytotoxicity.

Single Antigen Mismatched Related Donor Allogeneic Stem Transplants Have Similar Outcomes as Matched Unrelated Donor Allogeneic Stem Cell Transplants: A Single Center’s Experience.

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

Induction of Multiple Myeloma-Specific Cytotoxic T Lymphocytes Using HLA-A2.1-Specific CD19 and CD20 Peptides.

Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Ex-Vivo Expansion and mRNA Transfection of Cord Blood Derived Natural Killer Cells with Preserved Cytotoxicity.

Single Antigen Mismatched Related Donor Allogeneic Stem Transplants Have Similar Outcomes as Matched Unrelated Donor Allogeneic Stem Cell Transplants: A Single Center’s Experience.

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

Induction of Multiple Myeloma-Specific Cytotoxic T Lymphocytes Using HLA-A2.1-Specific CD19 and CD20 Peptides.

Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only